Periodic Reporting for period 1 - CERAMENT-BC (A novel bone implant with enhanced bone healing capacity)
Reporting period: 2016-09-01 to 2017-02-28
BONESUPPORT has developed and patented the CERAMENT™ material platform allowing for development of synthetic bone substitutes that are injectable, mimic natural bone, provide short-term support for fractures and bone voids with rapid pain relief and stabilization, as well as long-term osteoconductive support that allows for new bone formation. BONESUPPORT has the knowledge and experience in developing and commercializing combined products as, its portfolio comprises two products containing antibiotics.
The aim of this Feasibility Study was to develop a business plan for a new type of bone implant with enhanced bone healing capacity. The idea is to combine BONESUPPORT’s bone substitute CERAMENT™ with a Bone Active Drug.